Kwok Wang-Chun, Wong Jin-Ning Clarabel, Cheung Aaron, Tam Terence Chi-Chun
Department of Medicine, The University of Hong Kong, 102 Pokfulam Road, Pokfulam, Hong Kong SAR, China.
Vaccines (Basel). 2025 Feb 22;13(3):218. doi: 10.3390/vaccines13030218.
Chronic obstructive pulmonary disease (COPD) is often exacerbated by various viruses and bacteria, leading to acute episodes of worsening respiratory symptoms, which contribute significantly to the morbidity and mortality associated with COPD. Consequently, vaccination against these pathogens is recommended by numerous guidelines to safeguard COPD patients from adverse health outcomes. The Global Initiative for Chronic Obstructive Lung Disease (GOLD) recommendation advocates for vaccination against influenza, , respiratory syncytial virus (RSV), severe acute respiratory syndrome coronavirus (SARS-CoV2), pertussis, and varicella zoster. This review article will examine the current vaccination strategies recommended for adult COPD patients and will discuss the clinical benefits associated with these vaccines.
慢性阻塞性肺疾病(COPD)常因各种病毒和细菌而加重,导致呼吸道症状急性恶化发作,这对与COPD相关的发病率和死亡率有显著影响。因此,众多指南推荐针对这些病原体进行疫苗接种,以保护COPD患者免受不良健康后果的影响。慢性阻塞性肺疾病全球倡议(GOLD)建议接种流感、呼吸道合胞病毒(RSV)、严重急性呼吸综合征冠状病毒(SARS-CoV2)、百日咳和水痘带状疱疹疫苗。这篇综述文章将探讨目前推荐给成年COPD患者的疫苗接种策略,并讨论这些疫苗相关的临床益处。